With increasing life expectancies in most Western populations, the number of people experiencing age-associated cognitive impairment is increasing. Research is needed to identify factors that may help the elderly maintain or even improve cognitive function in the face of advancing age. This review evaluates whether dietary supplementation with natural pharmaceuticals can be used as a means to improve cognitive function or limit cognitive decline. The evidence surrounding popular supplements such as Ginkgo biloba, fish oils, Bacopa monnieri, polyphenol extracts, and vitamins is reviewed briefly. Potential mechanisms of action are also highlighted. This review also discusses challenges surrounding cognitive testing in psychopharmacological research, highlighting discrepancies between the domains of human cognition as described by contemporary models and as measured in clinical trials.
GrimaN. A.PaseM. P.MacPhersonH.PipingasA. (2012). (See References). A meta-analysis of randomized controlled trials showing that multivitamins have beneficial effects on free-recall memory.
2.
PaseM. P.StoughC. (2014). (See References). An article that discusses how contemporary models of human cognition can help improve standardization in psychopharmacological research
3.
SmithA. D.SmithS. M.de JagerC. A.WhitbreadP.JohnstonC.AgacinskiG.. . . RefsumH. (2010). (See References). An original study showing that B-vitamin supplementation slows the rate of brain atrophy.
4.
WilsonR. S.BeckettL. A.BarnesL. L.SchneiderJ. A.BachJ.EvansD. A.BennettD. A. (2002). (See References). A study showing that large individual differences exist in the rates of cognitive decline, suggesting that certain environmental factors may protect against cognitive aging.
5.
BaileyR. L.GahcheJ. J.LentinoC. V.DwyerJ. T.EngelJ. S.ThomasP. R.. . . PiccianoM. F. (2011). Dietary supplement use in the United States, 2003-2006. Journal of Nutrition, 141, 261–266.
6.
BirksJ.EvansJ. G. (2009). Ginkgo biloba for cognitive impairment and dementia. Cochrane Database of Systematic Reviews, 18(1), Article CD003120.
7.
ClarkeR.BennettD.ParishS.LewingtonS.SkeaffM.EussenS.. . . GrodsteinF. (2014). Effects of homocysteine lowering with B vitamins on cognitive aging: Meta-analysis of 11 trials with cognitive data on 22,000 individuals. American Journal of Clinical Nutrition, 100, 657–666.
8.
CorradaM. M.BrookmeyerR.Paganini-HillA.BerlauD.KawasC. H. (2010). Dementia incidence continues to increase with age in the oldest old: The 90+ study. Annals of Neurology, 67, 114–121.
9.
DeFeudisF. V.DrieuK. (2000). Ginkgo biloba extract (EGb 761) and CNS functions: Basic studies and clinical applications. Current Drug Targets, 1(1), 25–58.
10.
De JagerC. A.OulhajA.JacobyR.RefsumH.SmithA. D. (2012). Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial. International Journal of Geriatric Psychiatry, 27, 592–600.
11.
FjellA. M.WalhovdK. B. (2010). Structural brain changes in aging: Courses, causes and cognitive consequences. Reviews in the Neurosciences, 21, 187–221.
12.
FotuhiM.MohasselP.YaffeK. (2009). Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: A complex association. Nature Clinical Practice Neurology, 5, 140–152.
13.
GrimaN. A.PaseM. P.MacPhersonH.PipingasA. (2012). The effects of multivitamins on cognitive performance: A systematic review and meta-analysis. Journal of Alzheimer’s Disease, 29, 561–569. doi:10.3233/jad-2011-111751
14.
GrodsteinF.O’BrienJ.KangJ. H.DushkesR.CookN. R.OkerekeO.. . . SessoH. D. (2013). Long-term multivitamin supplementation and cognitive function in men: A randomized trial. Annals of Internal Medicine, 159, 806–814.
15.
HolcombL. A.DhanasekaranM.HittA. R.YoungK. A.RiggsM.ManyamB. V. (2006). Bacopa monniera extract reduces amyloid levels in PSAPP mice. Journal of Alzheimer’s Disease, 9, 243–251.
16.
Kesse-GuyotE.FezeuL.JeandelC.FerryM.AndreevaV.AmievaH.. . . GalanP. (2011). French adults’ cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: A post hoc analysis of the supplementation in vitamins and mineral antioxidants (SU.VI.MAX) trial. American Journal of Clinical Nutrition, 94, 892–899.
17.
Kris-EthertonP. M.HarrisW. S.AppelL. J. (2002). Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation, 106, 2747–2757. doi:10.1161/01.cir.0000038493.65177.94
18.
LindenbergerU. (2014). Human cognitive aging: Corriger la fortune?Science, 346, 572–578.
19.
MazereeuwG.LanctôtK. L.ChauS. A.SwardfagerW.HerrmannN. (2012). Effects of omega-3 fatty acids on cognitive performance: A meta-analysis. Neurobiology of Aging, 33, 1482.e1417–1482.e1429. doi:10.1016/j.neurobiolaging.2011.12.014
20.
McGrewK. S. (2009). CHC theory and the Human Cognitive Abilities project: Standing on the shoulders of the giants of psychometric intelligence research. Intelligence, 37, 1–10.
21.
MorrisonJ. H.HofP. R. (1997). Life and death of neurons in the aging brain. Science, 278, 412–419.
22.
NijveldtR. J.Van NoodE.Van HoornD. E. C.BoelensP. G.Van NorrenK.Van LeeuwenP. A. M. (2001). Flavonoids: A review of probable mechanisms of action and potential applications. American Journal of Clinical Nutrition, 74, 418–425.
23.
PaseM. P. (2012). Modifiable vascular markers for cognitive decline and dementia: The importance of arterial aging and hemodynamic factors. Journal of Alzheimer’s Disease, 32, 653–663. doi:10.3233/JAD-2012-120565
24.
PaseM. P.KeanJ.SarrisJ.NealeC.ScholeyA. B.StoughC. (2012). The cognitive-enhancing effects of Bacopa monnieri: A systematic review of randomized, controlled human clinical trials. Journal of Alternative and Complementary Medicine, 18, 647–652. doi:10.1089/acm.2011.0367
25.
PaseM. P.ScholeyA. B.PipingasA.KrasM.NolidinK.GibbsA.. . . StoughC. (2013). Cocoa polyphenols enhance positive mood states but not cognitive performance: A randomized, placebo-controlled trial. Journal of Psychopharmacology, 27, 451–458.
26.
PaseM. P.StoughC. (2013). Describing a taxonomy of cognitive processes for clinical trials assessing cognition. American Journal of Clinical Nutrition, 98, 509–510.
27.
PaseM. P.StoughC. (2014). An evidence-based method for examining and reporting cognitive processes in nutrition research. Nutrition Research Reviews, 27(2), 232–241.
28.
PipingasA.SilbersteinR. B.VitettaL.Van RooyC.HarrisE. V.YoungJ. M.NastasiJ. (2008). Improved cognitive performance after dietary supplementation with a Pinus radiata bark extract formulation. Phytotherapy Research, 22, 1168–1174.
29.
RussoA.BorrelliF. (2005). Bacopa monniera, a reputed nootropic plant: An overview. Phytomedicine, 12, 305–317.
30.
RyanJ.CroftK.MoriT.WesnesK.SpongJ.DowneyL.. . . StoughC. (2008). An examination of the effects of the antioxidant Pycnogenol® on cognitive performance, serum lipid profile, endocrinological and oxidative stress biomarkers in an elderly population. Journal of Psychopharmacology, 22, 553–562.
31.
ScholeyA.OwenL. (2013). Effects of chocolate on cognitive function and mood: A systematic review. Nutrition Reviews, 71, 665–681.
32.
SeshadriS.BeiserA.SelhubJ.JacquesP. F.RosenbergI. H.D’AgostinoR. B.. . . WolfP. A. (2002). Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. New England Journal of Medicine, 346, 476–483.
33.
Singh-ManouxA.KivimakiM.GlymourM. M.ElbazA.BerrC.EbmeierK. P.. . . DugravotA. (2012). Timing of onset of cognitive decline: Results from Whitehall II prospective cohort study. British Medical Journal, 344, Article d7622. Retrieved from http://www.bmj.com/content/344/bmj.d7622
34.
SmithA. D.SmithS. M.de JagerC. A.WhitbreadP.JohnstonC.AgacinskiG.. . . RefsumH. (2010). Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: A randomized controlled trial. PLoS ONE, 5(9), e12244. Retrieved from http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012244
35.
StonehouseW.ConlonC.PoddJ.HillS.MinihaneA.HaskellC.KennedyD. (2013). DHA supplementation improved both memory and reaction time in healthy young adults: A randomized controlled trial. American Journal of Clinical Nutrition, 97, 1134–1143.
36.
StoughC.LloydJ.ClarkeJ.DowneyL. A.HutchisonC. W.RodgersT.NathanP. J. (2001). The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology, 156, 481–484.
37.
StoughC. K.PaseM. P.CropleyV.MyersS.NolidinK.KingR.. . . ScholeyA. B. (2012). A randomized controlled trial investigating the effect of Pycnogenol and Bacopa CDRI08 herbal medicines on cognitive, cardiovascular, and biochemical functioning in cognitively healthy elderly people: The Australian Research Council Longevity Intervention (ARCLI) study protocol (ANZCTR12611000487910). Nutrition Journal, 11, Article 11. Retrieved from http://www.nutritionj.com/content/11/1/11
38.
WeinmannS.RollS.SchwarzbachC.VauthC.WillichS. N. (2010). Effects of Ginkgo biloba in dementia: Systematic review and meta-analysis. BMC Geriatrics, 10, 14.
WilsonR. S.BeckettL. A.BarnesL. L.SchneiderJ. A.BachJ.EvansD. A.BennettD. A. (2002). Individual differences in rates of change in cognitive abilities of older persons. Psychology and Aging, 17, 179–193.
